Translate Bio

About:

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

Top Investors: MRL Ventures Fund, Fidelity, The Baupost Group, SR One, Atlas Venture

Description:

Translate Bio is a biotechnology company that in biotechnology, RNA therapeutics, and rare diseases. Translate Bio is a therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.

Total Funding Amount:

$443M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Lexington, Massachusetts, United States

Founded Date:

2011-01-01

Contact Email:

bd(AT)ranarx.com

Founders:

Ankit Mahadevia